Literature DB >> 17713578

Negotiating the nucleosome: factors that allow RNA polymerase II to elongate through chromatin.

Jennifer A Armstrong1.   

Abstract

Initiation by RNA polymerase II (Pol II) involves a host of enzymes, and the process of elongation appears similarly complex. Transcriptional elongation through chromatin requires the coordinated efforts of Pol II and its associated transcription factors: C-terminal domain kinases, elongation complexes, chromatin-modifying enzymes, chromatin remodeling factors, histone chaperones (nucleosome assembly factors), and histone variants. This review examines the following: (i) the consequences of the encounter between elongating Pol II and a nucleosome, and (ii) chromatin remodeling factors and nucleosome assembly factors that have recently been identified as important for the elongation stage of transcription.

Mesh:

Substances:

Year:  2007        PMID: 17713578     DOI: 10.1139/O07-054

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  5 in total

Review 1.  CHD chromatin remodelers and the transcription cycle.

Authors:  Magdalena Murawska; Alexander Brehm
Journal:  Transcription       Date:  2011-11-01

2.  Control of chromatin structure by spt6: different consequences in coding and regulatory regions.

Authors:  Iva Ivanovska; Pierre-Étienne Jacques; Oliver J Rando; François Robert; Fred Winston
Journal:  Mol Cell Biol       Date:  2010-11-22       Impact factor: 4.272

3.  p53 chromatin epigenetic domain organization and p53 transcription.

Authors:  Chia-Hsin Su; Yih-Jyh Shann; Ming-Ta Hsu
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

4.  Histone variant H2A.Z and RNA polymerase II transcription elongation.

Authors:  Maria Soledad Santisteban; Mingda Hang; M Mitchell Smith
Journal:  Mol Cell Biol       Date:  2011-02-28       Impact factor: 4.272

5.  ChIP-seq and ChIP-exo profiling of Pol II, H2A.Z, and H3K4me3 in human K562 cells.

Authors:  Zenab F Mchaourab; Andrea A Perreault; Bryan J Venters
Journal:  Sci Data       Date:  2018-03-06       Impact factor: 6.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.